NDLI: Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case

Content Provider	Springer Nature Link
Author	Salminen, Jukka K. Tammela, Teuvo L. J. Auvinen, Anssi Murtola, Teemu J.
Copyright Year	2016
Abstract	Previous studies suggest that antiepileptic drugs with histone deacetylase (HDAC) inhibitor properties may have prostate cancer preventive effects. We evaluated the association between antiepileptic drug use and prostate cancer risk in a population-based case–control study. The study included all new prostate cancer cases diagnosed in Finland in 1995–2002 and matched controls (24,657 case–control pairs) identified from the Finnish Cancer Registry and the Population Register Center, respectively. Information on antiepileptic drug purchases was obtained from the national prescription reimbursement database. Odds ratios and their 95 % confidence intervals were estimated using age-adjusted and multivariable-adjusted conditional logistic regression analysis. Compared to never-users of antiepileptic drugs, the overall prostate cancer risk was decreased among users of phenobarbital, carbamazepine, and valproic acid (multivariable-adjusted odds ratio (OR) 0.47, 95 % CI 0.24–0.92; OR 0.82, 95 % CI 0.71–0.94, and OR 0.62, 95 % CI 0.42–0.92, respectively), but not among users of other antiepileptic drugs. Overall prostate cancer risk decreased in a dose-dependent manner by cumulative amount, duration and yearly dosage (intensity) of HDAC inhibitors valproic acid and carbamazepine. The risk of advanced prostate cancer was decreased only among carbamazepine users (OR 0.65, 95 % CI 0.44–0.96). Our results support possible prostate cancer preventive effects of HDAC inhibitors. However, also phenobarbital use was associated with decreased prostate cancer risk, despite not having HDAC inhibiting activity. The mechanism of action for antiepileptic drugs in prostate cancer deserves further study.
Starting Page	637
Ending Page	645
Page Count	9
File Format	PDF
ISSN	09575243
Journal	Cancer Causes & Control
Volume Number	27
Issue Number	5
e-ISSN	15737225
Language	English
Publisher	Springer International Publishing
Publisher Date	2016-04-01
Publisher Place	Cham
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Antiepileptic drugs Histone deacetylase inhibitors Prostatic neoplasms Case–control Cancer Research Biomedicine general Oncology Public Health Epidemiology Hematology
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case–control study

Lifetime body size and prostate cancer risk in a population-based case–control study in Sweden

Male infertility and prostate cancer risk: a nested case–control study

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada

Circulating fatty acids and prostate cancer risk in a nested case–control study: the Multiethnic Cohort

Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study

Statin use and prostate cancer risk in a large population-based setting

Risk of prostate cancer death in long-term users of warfarin: a population-based case–control study

Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case–control study

Similar Documents

The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case–control study

Lifetime body size and prostate cancer risk in a population-based case–control study in Sweden

Male infertility and prostate cancer risk: a nested case–control study

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

Use of oral anticoagulants and risk of prostate cancer: a population-based case–control study in Montreal, Canada

Circulating fatty acids and prostate cancer risk in a nested case–control study: the Multiethnic Cohort

Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study

Statin use and prostate cancer risk in a large population-based setting

Risk of prostate cancer death in long-term users of warfarin: a population-based case–control study

Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case–control study